Modern Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 19 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.40 M
- Revenue Growth 143.37%
- Profit Growth 284.46%
- Ebitda 216.07%
- Net Worth 20.22%
- Total Assets -16.98%
About Modern Life Sciences
Modern Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 February 2015 and has a history of Ten years. Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.40 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ajay Singh and Preetee Singh serve as directors at the Company.
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33111UP2015PTC068631
- Company No.
068631
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Modern Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Singh  | Director | 02-Feb-2015 | Current |
| Preetee Singh | Director | 02-Feb-2015 | Current |
Financial Performance of Modern Life Sciences.
Modern Life Sciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 143.37% increase. The company also saw a substantial improvement in profitability, with a 284.46% increase in profit. The company's net worth Soared by an impressive increase of 20.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Modern Life Sciences?
In 2017, Modern Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Brandadvert Private LimitedAjay Singh and Preetee Singh are mutual person
- Ravs Ecom Private Limited
Ajay Singh and Preetee Singh are mutual person
- Ramsun Naturals Private Limited
Ajay Singh and Preetee Singh are mutual person
Charges (Loans)
₹0
₹0.40 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2016 | Bank Of India | ₹0.40 M | Satisfied |
How Many Employees Work at Modern Life Sciences?
Unlock and access historical data on people associated with Modern Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Modern Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Modern Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.